Literature DB >> 32954433

Multifocal Necrotizing Leukoencephalopathy With Preferential Microglia Toxicity in a Patient Treated With Chimeric Antigen Receptor T-Cells and Review of the Literature.

Daniel F Marker1, Julia K Kofler1, Joseph A Mettenburg2, Mounzer E Agha3, Clayton A Wiley1.   

Abstract

Neurotoxic side effects of traditional systemic chemotherapy are abundantly described. The introduction of newly developed biologic therapeutics and cellular immune effector therapies has expanded the spectrum of neurotoxicity. Multifocal necrotizing leukoencephalopathy (MNL) is a pathologic condition of unknown etiology that has been observed in patients after prolonged critical illness. We observed a case of MNL in a patient treated with extensive multimodal therapy including chimeric antigen receptor T cells. A month before death, MRI demonstrated signs of inflammation and developing edema in brainstem structures. At autopsy the abnormal MRI regions showed a wave-like loss of microglia with hemorrhagic MNL in regions closest to the brain surface. These findings reiterate the susceptibility of white matter to antineoplastic therapy and suggest new mechanisms of neurotoxicity when traditional chemotherapy is combined with biologic or cellular effector therapy.
© 2020 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Chimeric antigen receptor T-cell (CAR-T) therapy; Inotuzumab-ozogamicin; Multifocal necrotizing leukoencephalopathy (MNL); Neurotoxicity

Year:  2020        PMID: 32954433      PMCID: PMC7559234          DOI: 10.1093/jnen/nlaa099

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  19 in total

1.  Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study.

Authors:  D R Spriggs; E Stopa; R J Mayer; W Schoene; D W Kufe
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

2.  Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema.

Authors:  Matthew Torre; Isaac H Solomon; Claire L Sutherland; Sarah Nikiforow; Daniel J DeAngelo; Richard M Stone; Henrikas Vaitkevicius; Ilene A Galinsky; Robert F Padera; Nikolaus Trede; Sandro Santagata
Journal:  J Neuropathol Exp Neurol       Date:  2018-10-01       Impact factor: 3.685

3.  Leukoencephalopathy and disseminated necrotizing leukoencephalopathy following intrathecal methotrexate chemotherapy and radiation therapy for central nerve system lymphoma or leukemia.

Authors:  Ji Yeon Kim; Sung Tae Kim; Do-Hyun Nam; Jung-Il Lee; Kwan Park; Doo-Sik Kong
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

4.  Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:  Sattva S Neelapu; Frederick L Locke; Nancy L Bartlett; Lazaros J Lekakis; David B Miklos; Caron A Jacobson; Ira Braunschweig; Olalekan O Oluwole; Tanya Siddiqi; Yi Lin; John M Timmerman; Patrick J Stiff; Jonathan W Friedberg; Ian W Flinn; Andre Goy; Brian T Hill; Mitchell R Smith; Abhinav Deol; Umar Farooq; Peter McSweeney; Javier Munoz; Irit Avivi; Januario E Castro; Jason R Westin; Julio C Chavez; Armin Ghobadi; Krishna V Komanduri; Ronald Levy; Eric D Jacobsen; Thomas E Witzig; Patrick Reagan; Adrian Bot; John Rossi; Lynn Navale; Yizhou Jiang; Jeff Aycock; Meg Elias; David Chang; Jeff Wiezorek; William Y Go
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

Review 5.  Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation.

Authors:  Amer Beitinjaneh; Alexander M McKinney; Qing Cao; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-04-24       Impact factor: 5.742

Review 6.  CD22: an inhibitory enigma.

Authors:  Jennifer A Walker; Kenneth G C Smith
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

7.  Neuronal expression of CD22: novel mechanism for inhibiting microglial proinflammatory cytokine production.

Authors:  Ryan T Mott; Ghania Ait-Ghezala; Terrence Town; Takashi Mori; Martina Vendrame; Jin Zeng; Jared Ehrhart; Michae Mullan; Jun Tan
Journal:  Glia       Date:  2004-05       Impact factor: 7.452

8.  Multifocal necrotizing leukoencephalopathy with pontine predilection in immunosuppressed patients: a clinicopathologic review of 16 cases.

Authors:  K H Anders; P S Becker; J K Holden; L R Sharer; M E Cornford; L A Hansen; R Hamilton; H V Vinters
Journal:  Hum Pathol       Date:  1993-08       Impact factor: 3.466

9.  Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma.

Authors:  L J Rubinstein; M M Herman; T F Long; J R Wilbur
Journal:  Cancer       Date:  1975-02       Impact factor: 6.860

Review 10.  ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.

Authors:  Daniel W Lee; Bianca D Santomasso; Frederick L Locke; Armin Ghobadi; Cameron J Turtle; Jennifer N Brudno; Marcela V Maus; Jae H Park; Elena Mead; Steven Pavletic; William Y Go; Lamis Eldjerou; Rebecca A Gardner; Noelle Frey; Kevin J Curran; Karl Peggs; Marcelo Pasquini; John F DiPersio; Marcel R M van den Brink; Krishna V Komanduri; Stephan A Grupp; Sattva S Neelapu
Journal:  Biol Blood Marrow Transplant       Date:  2018-12-25       Impact factor: 5.742

View more
  1 in total

1.  White matter cellular changes in ischemic injuries.

Authors:  Murad Alturkustani; Lee-Cyn Ang
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.